Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/55665
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAdhya, Shouvanik-
dc.date.accessioned2020-11-23T07:10:15Z-
dc.date.available2020-11-23T07:10:15Z-
dc.date.issued2020-12-
dc.identifier.issn0975-0959 (Online); 0301-1208 (Print)-
dc.identifier.urihttp://nopr.niscair.res.in/handle/123456789/55665-
dc.description676-680en_US
dc.description.abstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global pandemic in 2020 resulting a massive morbidity & mortality. The lung is the predominant organ involved in symptomatic patients with Coronavirus disease-2019 (COVID-19) along with involvement of other organs. Understanding the histopathological changes of lung and other organs in COVID-19 become essential for not only formulating future management protocols but also for determing prognosis. The collection of potentially contaminated tissues during the autopsy and further processing of them in histopathology laboratory with proper maintenance of safety protocol is of immense importance. A review of the available scientific articles shows the diffuse alveolar damage and microvascular thrombi are common observation found in lung tissue in patients who died due to COVID-19.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJBB Vol.57(6) [December 2020]en_US
dc.subjectAutopsyen_US
dc.subjectDiffuse alveolar damageen_US
dc.subjectGlomerulosclerosisen_US
dc.subjectMicrovascular thrombien_US
dc.titleHistopathological basis of COVID-19: A short reviewen_US
dc.typeArticleen_US
Appears in Collections:IJBB Vol.57(6) [December 2020]

Files in This Item:
File Description SizeFormat 
IJBB 57(6) 676-680.pdf450.64 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.